NEW YORK, Feb. 8 (GenomeWeb News) - Invitrogen plans to purchase Norwegian magnetic bead maker Dynal Biotech from its majority owner, Nordic Capital, and a co-investor for 2.5 billion Norwegian kroner ($380 million), the company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.
In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.
The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.
Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.